There is a new FDA-approved eye drop on the market called Vizz. This once-daily, prescription eye drop is said to help combat presbyopia, otherwise known as age-related blurry vision. Drugmaker Lenz ...

The central theme was moving beyond a lens-centric approach to vision, historically the foundation of presbyopia research, ...

Please provide your email address to receive an email when new articles are posted on . Presbyopia is a very common age-related process that negatively impacts visual performance and quality of life.

The first FDA-approved eye drops to treat age-related blurry near vision (presbyopia) has gone on sale in the US, offering a potential alternative to reading glasses for the estimated 128 million ...

Qlosi demonstrated consistent pupil size reduction and increasing rates of near visual acuity in patients with presbyopia ...

- Two presentations on the Phase 2b clinical trial show CSF-1 met the primary endpoints and achieved statistically significant and clinically meaningful improvements in distance-corrected near visual ...

A new drug that could help more than 128 million Americans read without needing glasses has been submitted to the Food and Drug Administration for approval. The investigational eye drop – called ...

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Presbyopia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...

Orasis Pharmaceuticals, an ophthalmic pharmaceutical company delivering solutions to reshape vision possibilities, has announced the availability of Starter Packs of Qlosi™ (pilocarpine hydrochloride ...

(MENAFN- GlobeNewsWire - Nasdaq) The global presbyopia market is rapidly expanding, driven by a growing aging population and advancements in diagnostic and treatment options. Presbyopia, an ...